Dr. Joseph Cox obtained his MD from Dalhousie University, and an MSc (Epidemiology) and Public Health and Preventive Medicine specialty training from McGill University. He is a consultant physician at the Chronic Viral Illness Service, Division of Infectious Diseases, McGill University Health Centre, and the Prevention and Control of Infectious Diseases Sector, Regional Department of Public Health, CIUSSS-Centre-Sud-de-l ’Île-de-Montréal. His research program focuses on understanding the determinants of HIV, STIs, and hepatitis C, and evaluating related prevention and care interventions, among vulnerable urban populations.
Dr. Julian Falutz is an assistant professor of medicine at McGill University and a Senior Physician in the Division of Geriatrics at the McGill University Health Center. He is also the director of the Comprehensive HIV and Aging Initiative of the Chronic Viral Illness Service at the McGill University Hospital Center, and was the past Director of the HIV Metabolic Clinic at the Immune Deficiency Treatment Center of the Montreal General Hospital. He completed his medical degree and a residency in general internal medicine with subspecialty training in internal medicine and geriatrics at McGill University. Dr. Falutz has focused his research on the interaction of metabolic complications, HIV/HAART-related body composition changes, and HIV disease.
Dr. Giada Sebastiani is a Professor of Medicine at McGill University (the first woman with this academic appointment in the Division of Gastroenterology and Hepatology) and a Clinician Scientist at the Research Institute of McGill University Health Centre in Montreal, Canada. She received a medical degree and specialized in internal medicine at the University of Padua, Italy. She trained in clinical and basic research at Harvard Medical School (US), University College of London (UK), University of Bordeaux (France), and the Lady Davis Institute for Medical Research (Montreal, Canada). Her work focuses on fatty liver disease, liver fibrosis, and non-invasive diagnostic tools in liver disease, with a current focus on at-risk populations, including people with diabetes, people living with HIV, patients with inflammatory bowel diseases, and women with polycystic ovary syndrome. She is a founding and steering committee member of the Canadian MASLD Network and panel member in the Consensus on Models of Care in fatty liver disease of the International Liver Foundation. Dr Sebastiani is the sole North American representative in the guidelines of the prestigious European AIDS Clinical Society (primary reviewer of the liver section). She was awarded the prestigious Clinical Research Salary Award "Merite" from Fonds Recherche Sante Quebec.
